A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
for
Non-small Cell Lung Cancer
Location: Sydney, Saint John, Scarborough ME, West Haven CT,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06692738
Phase3, Recruiting
Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers
for
Head and Neck Cancer, Lung Cancer, Lip Cancer, Lip Neoplasms,
Location: Stanford CA
Sponsor: Stanford University
Sex: All
Age: 18+
Code: NCT00568490
Recruiting
BostonGene and Exigent Genomic INsight Study
for
Breast Cancer, Non-small Cell Lung Cancer, Melanoma, Sarcoma
Location: Fort Wayne IN, Rogers AR, Houston TX, Tulsa OK,
Sponsor: BostonGene
Sex: All
Age: 18+
Code: NCT06272864
Recruiting
A Tool for Improving the Shared Decision-making Process in Patients With Non-small Cell Lung Cancer
for
Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8,
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT06122064
Recruiting
KRAS-Targeted Vaccine With Chemoimmunotherapy, Nivolumab and Ipilimumab for Patients With NSCLC
for
Non-Small Cell Lung Cancer
Location: Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sex: All
Age: 18 - 70+
Code: NCT05254184
Phase1, Recruiting
Interested in new lung cancer trials?
Get alerts for new trials in your area by subscribing now
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Improving Detection of Early Lung Cancer in a Diverse Population (IDEAL) Study
for
Lung Cancer, Pulmonary Nodule
Location: Vancouver
Sponsor: British Columbia Cancer Agency
Sex: All
Age: 50 - 70+
Code: NCT06628102
Recruiting
Pulsed Low Dose Rate Radiation With Concurrent Chemotherapy for Non-Small Cell Lung Cancer and Esophageal Cancer
for
Lung Cancer, Esophageal Cancer
Location: Philadelphia PA
Sponsor: Fox Chase Cancer Center
Sex: All
Age: 18+
Code: NCT03094884
Phase1, Recruiting
Excretion of Acetylamantadine (AA) by Lung Cancer Patients During a Chemotherapy Regimen
for
Lung Cancer
Location: Winnipeg
Sponsor: University of Manitoba
Sex: All
Age: 19+
Code: NCT02331290
Recruiting
Personalized Escalation of Consolidation Treatment Following Chemoradiotherapy and Immunotherapy in Stage III NSCLC in Stage III NSCLC
for
Non Small Cell Lung Cancer, NSCLC, Stage III, Nsclc
Location: Stanford CA
Sponsor: Maximilian Diehn
Sex: All
Age: 18+
Code: NCT04585490
Phase3, Recruiting
Endobronchial Ultrasound-guided Transbronchial Needle Aspiration for Lymph Node Staging in Patients With Non-small Cell Lung Cancer Pursuing Stereotactic Body Radiotherapy (SBRT)
for
Lung Cancer
Location: Toronto
Sponsor: University Health Network, Toronto
Sex: All
Age: 18+
Code: NCT01786590
Recruiting
Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy